Oestrogen receptive positive breast cancer can be treated by drugs, such as fulvestrant, that interfere with the action of oestrogen.
Category: Breast cancer
DNA nanorobots target HER2-positive breast cancer cells
According to the Mayo Clinic, about 20% of breast cancers make abnormally high levels of a protein called human epidermal
Women perceive the potential benefits of mammograms to be more important than the potential harms
In 2009, disagreement in the health community arose following a recommendation from the United States Preventive Services Task Force (USPSTF)
Chemotherapy or not?
Case Western Reserve University researchers and partners, including a collaborator at Cleveland Clinic, are pushing the boundaries of how “smart”
Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance
Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance by attacking the disease along two separate gene
Preventing triple negative breast cancer from spreading
A breast cancer cell is like a house with three locks on the front door. Keys, or receptors, allow drugs
Fuel for Drug Resistance
About one in eight women in the U.S. will develop breast cancer in her lifetime. The vast majority of these
Breast cancer: Reducing this amino acid could make drugs more effective
Scientists from Harvard Medical School, in Boston, MA, recently made “unexpected” discovery about estrogenreceptor-positive (ER-positive) breast cancer in a study conducted with
New formula better predicts speed of tumor growth in 12 cancers
University at Buffalo researchers have developed a new method to more accurately predict tumor growth rates, a crucial statistic used
Estrogen byproducts may predict outlook
New research finds an association between the ratio of two estrogen metabolites and the risk of all-cause mortality among women
